Phase I Clinical Trial of DA-6886 in Healthy Male Subjects
NCT01633723
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
105
Enrollment
INDUSTRY
Sponsor class
Conditions
Irritable Bowel Syndrome
Interventions
DRUG:
DA-6886
DRUG:
Placebo of DA-6886
Sponsor
Dong-A ST Co., Ltd.